Current and emerging therapies for the management of functional gastrointestinal disorders

Orla F. Craig; Eamonn M.M. Quigley

doi:10.1177/2040622310389507

Current and emerging therapies for the management of functional gastrointestinal disorders

Orla F. Craig, Eamonn M.M. Quigley

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

The functional gastrointestinal disorders are common disorders that are associated with significant quality-of-life impairment and considerable economic burden on the healthcare system. They are frequently associated with a comorbid psychiatric condition; this, together with a striking lack of effective pharmacological therapies, means they represent a considerable therapeutic challenge to the treating physician. In this overview, we examine the evidence to support the use of agents currently used in the management of the more common functional gastrointestinal disorders and review emerging therapies.

Original language	English (US)
Pages (from-to)	87-99
Number of pages	13
Journal	Therapeutic Advances in Chronic Disease
Volume	2
Issue number	2
DOIs	https://doi.org/10.1177/2040622310389507
State	Published - Mar 2011

Keywords

Antibiotics
Antidepressants
Cognitive behavioural therapy
Functional dyspepsia
Functional gastrointestinal disorders
Functional heartburn
Irritable bowel syndrome
Probiotics
Serotonin

ASJC Scopus subject areas

Medicine (miscellaneous)

Access to Document

10.1177/2040622310389507

Cite this

@article{50ce8f28e86048f19294400ebabaf095,

title = "Current and emerging therapies for the management of functional gastrointestinal disorders",

abstract = "The functional gastrointestinal disorders are common disorders that are associated with significant quality-of-life impairment and considerable economic burden on the healthcare system. They are frequently associated with a comorbid psychiatric condition; this, together with a striking lack of effective pharmacological therapies, means they represent a considerable therapeutic challenge to the treating physician. In this overview, we examine the evidence to support the use of agents currently used in the management of the more common functional gastrointestinal disorders and review emerging therapies.",

keywords = "Antibiotics, Antidepressants, Cognitive behavioural therapy, Functional dyspepsia, Functional gastrointestinal disorders, Functional heartburn, Irritable bowel syndrome, Probiotics, Serotonin",

author = "Craig, {Orla F.} and Quigley, {Eamonn M.M.}",

year = "2011",

month = mar,

doi = "10.1177/2040622310389507",

language = "English (US)",

volume = "2",

pages = "87--99",

journal = "Therapeutic Advances in Chronic Disease",

issn = "2040-6223",

publisher = "SAGE Publications Inc.",

number = "2",

}

TY - JOUR

T1 - Current and emerging therapies for the management of functional gastrointestinal disorders

AU - Craig, Orla F.

AU - Quigley, Eamonn M.M.

PY - 2011/3

Y1 - 2011/3

N2 - The functional gastrointestinal disorders are common disorders that are associated with significant quality-of-life impairment and considerable economic burden on the healthcare system. They are frequently associated with a comorbid psychiatric condition; this, together with a striking lack of effective pharmacological therapies, means they represent a considerable therapeutic challenge to the treating physician. In this overview, we examine the evidence to support the use of agents currently used in the management of the more common functional gastrointestinal disorders and review emerging therapies.

AB - The functional gastrointestinal disorders are common disorders that are associated with significant quality-of-life impairment and considerable economic burden on the healthcare system. They are frequently associated with a comorbid psychiatric condition; this, together with a striking lack of effective pharmacological therapies, means they represent a considerable therapeutic challenge to the treating physician. In this overview, we examine the evidence to support the use of agents currently used in the management of the more common functional gastrointestinal disorders and review emerging therapies.

KW - Antibiotics

KW - Antidepressants

KW - Cognitive behavioural therapy

KW - Functional dyspepsia

KW - Functional gastrointestinal disorders

KW - Functional heartburn

KW - Irritable bowel syndrome

KW - Probiotics

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=79960055925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960055925&partnerID=8YFLogxK

U2 - 10.1177/2040622310389507

DO - 10.1177/2040622310389507

M3 - Review article

C2 - 23251744

AN - SCOPUS:79960055925

SN - 2040-6223

VL - 2

SP - 87

EP - 99

JO - Therapeutic Advances in Chronic Disease

JF - Therapeutic Advances in Chronic Disease

IS - 2

ER -

Current and emerging therapies for the management of functional gastrointestinal disorders

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this